Pharmaceutical Exporter from India to Tunisia.
Every imported medicine in Tunisia has one buyer. The Pharmacie Centrale de Tunisie (PCT) holds the import monopoly under Law 90-105 of 1990, supplies public hospitals directly, and supplies imported medicines to the private wholesale distributors and pharmacies. PCT buys products that hold a Tunisian marketing authorisation (AMM), so registration comes before any price. M Care Exports works with the Indian manufacturer on the Tunisian registration file, prepares PCT offers, and ships to Rades with the batch paperwork in order.
Registration and the marketing authorisation (AMM)
A medicine needs a Tunisian marketing authorisation, the autorisation de mise sur le marché (AMM), before it can be sold. Registration has been run by the Ministry of Health's Direction de la Pharmacie et du Médicament (DPM). Law 2023-2 of 12 July 2023 created the Agence nationale du médicament et des produits de santé, which takes over registration and import authorisations once it is set up; until then the ministry's existing structures keep those tasks (Article 14). Ask your Tunisian partner which body receives a new file. We prepare Tunisian dossiers in CTD format and in French, and confirm for each file how an existing EU dossier can be used.
Time to authorisation varies with the product and how complete the file is. The CTD carries the quality (chemistry, manufacturing and controls) data, bioequivalence data where it applies, and the clinical overview, and we cross-reference it to the Indian manufacturer's site master file and the inspection record that supports the GMP claim.
PCT buys in two ways. It runs a competitive tender when a medicine is off-patent and at least two suppliers hold a valid AMM for it; tenders are national or international, cover both the hospital and the pharmacy sector, and are larger in hospitals. Where few products are registered for a medicine, or prescribers need a specific product, PCT buys by direct agreement. So the commercial questions for an Indian product are whether it is registered, and how many other registered products compete with it.
Payment terms, currency and the documents a shipment must carry are set in each PCT contract or call. We agree them before the first shipment and prepare the invoice, certificate of origin and batch documents to match, so payment is not held up by document queries.
Call & WhatsApp the Mumbai desk: +91 70156 05768 · [email protected] · Mon–Sat 09:30–18:30 IST
Six capability lines that fit how Tunisia actually buys
DPM dossier preparation in French CTD format
We build full Common Technical Document files in French. For molecules that already hold an EU marketing authorisation we confirm with the regulator how the EU dossier can be reused. For purely Indian-registered molecules we run the full module-by-module preparation, including stability data, bioequivalence references, and the GMP attestation tied to the Indian manufacturing site.
PCT tender offers
PCT tenders off-patent medicines once at least two suppliers hold a valid AMM, through national and international calls. We prepare the offer with the manufacturer against each call: the technical file, the certificate of pharmaceutical product, GMP and free-sale certificates, batch certificates of analysis, samples where the call asks for them, and the price offer on the terms the call sets.
Direct-agreement supply
Where few products are registered for a medicine, or prescribers need a specific product, PCT buys by direct agreement rather than tender. Medicines still under patent cannot go to tender under PCT's rules, so originator brands are bought this way too. We supply against those orders with batch certificates of analysis and complete shipping documents, and help the manufacturer keep the registration file current.
Oncology and biologics
Biosimilars of trastuzumab, rituximab and bevacizumab, and oncology supportive care, from WHO-GMP certified Indian manufacturers. Once the originator's patent has expired and at least two suppliers hold a Tunisian AMM, PCT can put the molecule to tender; we provide the comparative analytical data and inspection evidence the manufacturer holds.
Sea and air freight to Tunis
Sea freight from Jawaharlal Nehru Port at Mumbai discharges at Rades, the container port serving Tunis, with Sfax as the southern alternative. Cold-chain lots move in reefer containers or by air, and we send the shipping documents ahead of arrival so clearance does not wait on paperwork.
Commercial and shipping documents
Invoice, packing list, certificate of origin, batch certificates of analysis and the manufacturer's GMP and free-sale certificates, prepared to the contract or letter-of-credit terms the buyer's bank works to, so payment is not held up by document queries.
How a container moves from our Mumbai depot to Tunisian discharge
Sea freight leaves Jawaharlal Nehru Port at Mumbai for Rades, the container port serving Tunis, through the Suez Canal; transit time depends on the carrier's routing and transhipment port, and we confirm it at booking. Sfax is the alternative when the consignee's distribution is in the south. We send the shipping documents to the consignee ahead of arrival so customs clearance can start when the container lands.
Cold-chain consignments move in reefer containers with data loggers, or by air in temperature-controlled packaging for biologics with tighter stability windows. Routing and packaging are agreed with the buyer before the first shipment.
Each shipment carries the invoice in the contract currency, the batch certificate of analysis, the manufacturer's free-sale certificate, a certificate of origin from an Indian chamber of commerce and the product's AMM number, with the PCT order or tender reference on the documents so each consignment can be matched to its contract.
Where Indian supply fits in Tunisia
Tunisian factories supply a little over 70 percent of the volume sold through pharmacies, according to PCT, and local production also leads by volume in hospitals. An imported product has its best case where Tunisian plants do not make the medicine: oncology medicines and biosimilars, other biologics, specialty and complex generics, and products still under patent. Commodity solid orals are the hardest place for an import to compete.
For off-patent medicines with several registered suppliers, PCT's tenders decide the volume, so price and complete documents matter most. For medicines with few registrations, the work is in obtaining the AMM and keeping supply reliable once PCT buys by direct agreement.
For cold-chain biologics such as insulin analogues and oncology biosimilars, we start from manufacturers whose GMP inspection history and stability data can support a Tunisian registration file.
An Indian export desk that already understands PCT
Most of the work for Tunisia happens before any price is quoted. For each product we check whether it holds a Tunisian AMM, whether it is off-patent with other registered suppliers (which puts it into PCT's tender cycle) or one of few registrations (which means direct agreement), and what the manufacturer's file needs before a submission. That tells the buyer and the manufacturer which route a product will take before anyone spends money on a dossier.
The second piece is the file itself. We prepare the CTD in French with the cross-references a reviewer needs, package the manufacturer's inspection evidence (EU-GMP, EDQM, MHRA or USFDA where the site has it), and have bioequivalence or comparability summaries translated early rather than at the deadline.
What Tunisian buyers ask before they place a Mumbai order
Is direct private import to Tunisia possible, or does everything go through Pharmacie Centrale de Tunisie?
Imported medicines go through PCT. Under Law 90-105 of 1990, the Pharmacie Centrale de Tunisie holds the monopoly on importing medicines. It supplies public hospitals directly and supplies imported medicines to the private wholesale distributors and pharmacies, so a buyer in Tunisia obtains an imported product from PCT rather than importing it. What a supplier controls is registration: PCT buys products that hold a Tunisian marketing authorisation (AMM), by tender when the medicine is off-patent and at least two suppliers hold an AMM, and by direct agreement where few products are registered or prescribers need a specific one.
How long does a Tunisian marketing authorisation (AMM) take?
It varies with the product and how complete the file is; questions on stability or on the manufacturing site's GMP evidence add time. We give an estimate for each product at enquiry. Law 2023-2 of 12 July 2023 moves registration to the new Agence nationale du médicament et des produits de santé once the agency is set up, so confirm the current filing route before planning around a date.
What is involved in preparing a PCT tender offer?
PCT runs national and international calls for off-patent medicines where at least two suppliers hold a valid AMM, and each call sets its own documents and terms. We prepare the offer with the manufacturer against the call's own list, which usually covers the AMM, the technical file, the certificate of pharmaceutical product, GMP and free-sale certificates, batch certificates of analysis, samples where requested, and the price offer, and we check it against the call before submission.
How are payment and currency handled?
Payment terms, currency and the documents required are set in each PCT contract or call. We agree them before the first shipment and prepare the commercial documents to match exactly, so the buyer's bank has no reason to query them.
Which Tunisian port should we route an ambient pharmaceutical container through?
Rades, the container port serving Tunis, is the usual discharge point for sea freight from Mumbai, with Sfax as the alternative in the south. We send the shipping documents ahead of arrival so customs clearance can start when the container lands, which keeps demurrage down and protects temperature-controlled lots.
What therapeutic areas does M Care prioritise for Tunisia versus competing with local manufacturers?
Products Tunisian factories do not make: oncology medicines and biosimilars, other biologics, specialty and complex generics, transplant medicines, and originator brands still under patent. Local production supplies a little over 70 percent of the volume sold through pharmacies, according to PCT, so commodity solid orals are the hardest place for an imported product to compete.
How should a dossier for Tunisia be prepared?
In CTD format and in French, with the Indian manufacturer's site master file and inspection records cross-referenced to support the GMP claim. Where the molecule already holds an EU marketing authorisation, we confirm with the regulator how much of the EU dossier can be reused. A complete, consistent file is what gets through administrative validation without being sent back.
Open a Tunisian working file with a desk that already knows PCT
PCT tender and direct-agreement offers
Offer documents prepared with the manufacturer against each PCT call, and supply against direct-agreement orders for products with few registrations.
AMM registration files
CTD files in French for a Tunisian AMM, reusing the EU dossier where the authority allows it for molecules already holding an EU marketing authorisation.
Documents that clear first time
Invoice, certificate of origin, batch certificates and GMP papers prepared to the contract or letter-of-credit terms, so payment and clearance are not held up by document queries.
Top categories we ship to Tunisia
Anti-infectives
Second-line antibiotics, anti-retroviral combinations, anti-tuberculosis regimens and antifungals, supplied to PCT for AMM-registered products by tender or direct agreement.
Oncology biosimilars
Trastuzumab, rituximab and bevacizumab biosimilars and oncology supportive care for Tunisian hospitals, supplied through PCT.
Cardiovascular
Specialty cardiovascular lines including anticoagulants, heart-failure therapies, and dyslipidaemia molecules where local Tunisian manufacturing capacity is constrained or absent.
Diabetes and endocrine
Insulin analogues, incretin therapies and endocrine specialty lines, delivered by cold chain to Tunis with the AMM and batch documentation.
Respiratory
Inhalers and other asthma and COPD therapies from WHO-GMP certified Indian manufacturers, supplied through PCT to hospitals and pharmacies once registered.
General and OTC
Selective OTC and general-prescription lines that fill specific Tunisian retail gaps where local manufacturing capacity does not extend or paediatric scarce-strength demand persists.
Services that sit underneath every Tunisia shipment
WHO-GMP compliance
Manufacturing-site GMP evidence packaged for Tunisian registration files and PCT tender evaluation, including EU-GMP, EDQM, MHRA or USFDA inspection histories where the site has them.
Dossier preparation (CTD)
French-language CTD preparation for a Tunisian AMM, reusing EU dossier content where the molecule already holds an EU marketing authorisation.
Cold-chain validation
Temperature-mapped reefer and active-air-freight container audits from Mumbai cold-room loading through Port de Rades discharge, with dual-logger evidence packaged for institutional acceptance testing.
Send the molecule list. We send back the route each product takes.
Share the molecules you need and whether they are for hospitals or pharmacies. Within five working days we return, for each product, its Tunisian AMM status, whether PCT would buy it by tender or by direct agreement, what the registration file still needs, and the documents the first shipment will carry. No upfront commitment.
Start a Tunisia enquiry → Back to all marketsBuying for repeat supply? Open a trade account for a named account manager and priced quotes.
